​CE for Pharmacists: Pharmacist's Role in Demystifying the Fears of Biosimilar Humira® Use in Rheumatology

by Michael Nome, 2024 PharmD Candidate, Judy Zheng, 2024 PharmD Candidate, Brandon Stevens, 2024 PharmD Candidate, Shayne Hughes, 2024 PharmD Candidate, Chinh Kieu, 2023 PharmD Candidate 

​Learning Objectives

• Recognize the current climate and trend of biosimilar use in rheumatology
• Acknowledge various challenges delaying the adoption of biological products
• Describe the FDA regulatory pathway for biosimilars and the impact of patents on patient care
• List various strategies used to support biosimilar uptake
• Articulate the relevance of biosimilar use to practicing pharmacists
• Recognize how pharmacists in different practice settings can be leveraged to improve biosimilar accessibility

​Keywords: Biosimilar Pharmaceuticals, Pharmacists, Quality of Life, Rheumatology, Rheumatic Diseases, Health Services Accessibility, Drug Industry, Biological Therapy, Patient Care, Perception

​Download PDF 

2022 November/December Table of Contents